跳至主要内容
临床试验/NCT05537181
NCT05537181进行中(未招募)不适用

Evaluation of the Combination Treatment With BTL-899 and HPM-6000UF Devices for Abdominal and Pelvic Floor Muscle Strengthening and Overall Improvement in Quality of Life in Elderly Patients

BTL Industries Ltd.6 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2022年2月4日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
39
试验地点
6
主要终点
Assessment of subject's quality of life based on Subject Satisfaction and Experience Questionnaire

研究概览

简要总结

This study will evaluate the clinical efficacy of the BTL-899 and HPM-6000UF devices in combination for non-invasive strengthening of the core muscles and overall improvement in quality of life in elderly patients.

详细描述

The study is a prospective, multicenter single-arm, open-label, interventional study. The subjects will be enrolled and assigned into a single study group. Subjects will be required to complete seven (7) treatment visits and two (2) follow-up visits - 1 month and 3 months after the final treatment.

At the baseline visit, medical history will be assessed. Inclusion and exclusion criteria will be verified, and informed consent will be signed. Digital photographs will be taken, waist circumference will be measured, abdominal muscle strength will be measured with a pressure biofeedback device.

The two devices will be used separately in two different treatments. However one treatment visit can comprise both treatments. The BTL-899 will be applied over the abdomen, and the device will induce visible muscle contractions along with mild heating of the muscles. Four (4) treatments once a week will be delivered. The HPM-6000UF device will induce pelvic floor muscle contractions. Six (6) treatments 2-4 days apart will be delivered. There will be three (3) visits where both treatments will be applied consecutively, starting with BTL-899, followed by the therapy with HPM-6000UF.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy male or female subjects aged 60 years or older (postmenopause when female),
  • BMI ≤35kg/m2 seeking treatment for strengthening their pelvic floor or abdominal muscles
  • Subjects should be able to understand the investigative nature of the treatment, the possible benefits and side effects, and must sign the Informed Consent Form.
  • Subjects willing and able to abstain from partaking in any concurrent treatments on abdomen and pelvic floor other than the study procedures during study participation.
  • Willingness to comply with study instructions, to return to the clinic for the required visits, and to have photographs taken.

排除标准

  • Electronic implants (such as cardiac pacemakers, defibrillators, and neurostimulators)
  • Metal implants in the treated area
  • Drug pumps
  • Malignant tumor
  • Pulmonary insufficiency
  • Injured or otherwise impaired muscles in the treated area
  • Cardiovascular diseases
  • Disturbance of temperature or pain perception
  • Hemorrhagic conditions
  • Septic conditions and empyema
  • Acute inflammations in the treated area
  • Systemic or local infection such as osteomyelitis and tuberculosis
  • Contagious skin disease
  • Elevated body temperature
  • Poor healing and unhealed wounds in the treatment area
  • Following recent surgical procedures when muscle contraction may disrupt the healing process
  • Graves' disease

结局指标

主要结局

Assessment of subject's quality of life based on Subject Satisfaction and Experience Questionnaire

时间窗: 5 months

Change in subject's quality of life based on Subject Satisfaction and Experience

Assessment of core muscles strength measured by pressure biofeedback device

时间窗: 5 months

Change in core muscles strength measured by pressure biofeedback device

次要结局

未报告次要终点

研究者

发起方
BTL Industries Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验